Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years. Zivadinov R, Hojnacki D, Bergsland N, Kennedy C, Hagemeier J, Melia R, Ramasamy DP, Durfee J, Carl E, Dwyer MG, et al. Eur J Neurol. 2016 Mar 21. PMID: 26998905. Abstract CommentRecommendBookmarkWatch